Scientists in Singapore have developed a novel strategy to control dengue fever by releasing male mosquitoes infected with a specific bacteria, Wolbachia. This innovative approach targets Aedes aegypti mosquitoes, the primary vector for the virus. When these Wolbachia-infected males mate with wild females, their eggs fail to hatch, a phenomenon known as cytoplasmic incompatibility. This method has shown significant promise in reducing mosquito populations and, consequently, the incidence of dengue.
A large-scale community trial divided residential areas into intervention groups receiving Wolbachia mosquitoes and control groups. The results were striking: mosquito populations in intervention areas dropped by approximately 85% compared to control areas. Crucially, symptomatic dengue cases in the intervention zones fell by over 70%.
These findings suggest that releasing sterile male Wolbachia mosquitoes can effectively suppress vector populations and lower dengue infection risks in urban environments. While the efficacy may vary in different locations, this research offers a powerful new tool to complement existing dengue control measures, particularly in densely populated tropical regions where the disease is endemic.